Columbia Suicide Severity Rating Scale (C-SSRS Screener)
Why Use
Suicide risk assessment is complex, and the C-SSRS can assist clinicians with their evalulation of patients in the ER to predict their overall risk and need for admission. Extensively validated in various patient populations, including children as young as five years old and adolescents. Recommended and adopted by the US Food and Drug Administration for clinical trials ( FDA 2012 ) and Centers for Disease Control to define and stratify suicidal ideation and behavior ( Crosby 2011 ).
When to Use
Emergency patients in whom there is concern for suicidality.
Formula
Pearls / Pitfalls
Often based entirely on patient-reported items, but also allows for integration of information from other sources (e.g. family and friends, healthcare professionals, hospital records, coroner’s report/death certificate). Best validated in emergency settings (i.e., to triage patients in the emergency department) and also has limited validation in the outpatient psychiatry setting ( Viguera 2015 ).
Critical Actions
Should not replace a complete clinical evaluation; may be employed as an initial screener to guide a clinician’s suicide risk assessment and to help stratify patients into low, moderate, or high risk categories.
Advice
Protocols vary by institution, but most suggest complete assessment by a psychiatrist and inpatient admission for high risk patients (level 4-5). Low and moderate risk patients should be reassessed by a trained clinician and may not require admission.
More Information
Interpretation: Suicidal ideation ( most severe in the past month ) Risk of suicide Management 1-2 Low Behavioral health referral at discharge 3, or reported suicidal behavior in lifetime Moderate Behavioral health consult (psychiatric nurse/social worker) and consider patient safety precautions 4-5, or reported suicidal behavior within the past three months High Immediate notification of physician and/or behavioral health and patient safety precautions